We are live on ! Find out more
ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

1 hedge funds and large institutions have $5.79K invested in Alexion Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more capital invested

Capital invested by funds: $5.52K → $5.79K (+$268)

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ALXN Hedge Fund Activity: Q3 2025 in Review

1 of the 7,638 institutional investors tracked by Wall St. Rank reported a position in Alexion Pharmaceuticals (ALXN) for Q3 2025, worth a combined $5.79K — up 4.9% from $5.52K a quarter earlier.

Fund positioning in ALXN was balanced in Q3 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Alexion Pharmaceuticals (ALXN) as of Q3 2025, unchanged from Q2 2025.
  • Funds reported $5.79K of Alexion Pharmaceuticals stock for Q3 2025, up 4.9% quarter-over-quarter.
  • 0 funds opened new Alexion Pharmaceuticals positions in Q3 2025 and 0 closed out.

Based on aggregated 13F filings for Q3 2025.